An evaluation of the variation and underuse of clozapine in the United Kingdom

This is the authors' abstract. We don't add key points for this paper.

There is clear regional inequity in access to the most effective treatment in refractory schizophrenia in England. Strategies to increase clozapine use, by overcoming both real and perceived barriers, are urgently necessary to reduce treatment inequity for patients with refractory schizophrenia.